Breast cancer is the most common type of cancer in women1, while the triple-negative phenotype (negative for estrogen (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2/neu)) has the poorest survival rate2. This evidence concerns the gene ERBB2 and cancer.